Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Natalia Anna Gablo"'
Autor:
Monika Vlachová, Jana Gregorová, Petra Vychytilová-Faltejsková, Natalia Anna Gabło, Lenka Radová, Lenka Pospíšilová, Martina Almáši, Martin Štork, Zdeňka Knechtová, Jiří Minařík, Tereza Popková, Tomáš Jelínek, Roman Hájek, Luděk Pour, Lucie Říhová, Sabina Ševčíková
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 23, p 14765 (2022)
Extramedullary multiple myeloma (EMD) is an aggressive disease; malignant plasma cells lose their dependence in the bone marrow microenvironment and migrate into tissues. EMD is a negative prognostic factor of survival. Using flow cytometry and next-
Externí odkaz:
https://doaj.org/article/bd03d2acc3004026980d969d0d935abe
Autor:
Natalia Anna Gablo, Bretislav Gal, Jiri Sana, Dominik Gurin, Markéta Hermanová, Tomas Kazda, Zuzana Horáková, Pavel Šlampa, Karolina Trachtova, Marek Slávik, Ondrej Slaby, Pavel Smilek, Parwez Ahmad
Publikováno v:
Cellular Oncology. 43:505-511
Progress in radiation therapy of head and neck squamous cell carcinomas (HNSCCs) is logically linked to the development of molecular predictors that would help to enhance individually tailored treatment. MicroRNA (miRNA) expression profiles in tumors
Publikováno v:
Current Genomics
Pancreatic cancer (PaC) is one of the most lethal cancers, with an increasing global incidence rate. Unfavorable prognosis largely results from associated difficulties in early diagnosis and the absence of prognostic and predictive biomarkers that wo
Autor:
Pavel Skalicky, Vladimír Procházka, Tomáš Grolich, Zdenek Kala, Jan Hlavsa, Karolina Trachtova, Josef Srovnal, Martin Lovecek, Ondrej Slaby, Ioana Berindan-Neagoe, Natalia Anna Gablo, Igor Kiss, Alona Rehulkova
Publikováno v:
Journal of Clinical Medicine
Volume 9
Issue 8
Journal of Clinical Medicine, Vol 9, Iss 2440, p 2440 (2020)
Volume 9
Issue 8
Journal of Clinical Medicine, Vol 9, Iss 2440, p 2440 (2020)
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal and aggressive cancers with a less than 6% five-year survival rate. Circulating microRNAs (miRNAs) are emerging as a useful tool for non-invasive diagnosis and prognosis estimation in
Autor:
Petra Vychytilova-Faltejskova, Markéta Hermanová, Igor Kiss, Zdenek Kala, Vladimír Procházka, Natalia Anna Gablo, Jan Hlavsa, Ondrej Slaby, Petr Karasek
Publikováno v:
Cancer Genomics - Proteomics. 15:321-327
Blood plasma microRNAs (miRNAs) are emerging as a clinically useful tool for non-invasive detection and prognosis estimation in various cancer types including pancreatic ductal adenocarcinoma (PDAC). The aim of the present study was to provide an ind
Autor:
Zuzana Horáková, Ondrej Slaby, Parwez Ahmad, Bretislav Gal, Dominik Gurin, Tomas Kazda, Markéta Hermanová, Marek Slávik, Lenka Radová, Jiri Sana, Pavel Smilek, Pavel Šlampa, Natalia Anna Gablo
Publikováno v:
Cancer genomicsproteomics. 16(2)
Background/Aim: Head and neck cancers are a heterogenous group of epithelial tumors represented mainly by squamous cell carcinomas (HNSCC), which are the sixth most common type of cancer worldwide. Surgery together with radiotherapy (RT) is among the
Autor:
Jaroslav Juracek, Jiri Sana, Marek Svoboda, Marek Slávik, Natalia Anna Gablo, Markéta Hermanová, Marek Vecera, Tana Machackova, Pavel Šlampa, Pavel Smilek, Ondrej Slaby, Parwez Ahmad
Publikováno v:
Cancer Research. 78:5406-5406
Introduction: Head and neck cancers are the sixth most common cancers worldwide mainly represented by the squamous cell carcinoma (HNSCC). Very important treatment modality in HNSCC is radiotherapy (RT). Closed as well as ongoing clinical trials are
Autor:
Jiri Sana, Leos Kren, Natalia Anna Gablo, Marek Vecera, Pavol Mojak, Markéta Hermanová, Martin Smrčka, Štefan Reguli, Michal Filip, Radim Jančálek, Ondrej Slaby, Radim Lipina, Jaroslav Juracek, Romana Bútová, Tana Machackova
Publikováno v:
Cancer Research. 78:2459-2459
Introduction: Glioblastoma (GBM) is the most frequent primary brain tumor of astrocytic origin. The prognosis is unfavourable with the median overall survival (OS) being between 12 and 15 months from diagnosis. Identification of new therapeutic targe
Autor:
Petra Vesela, Tomáš Andrašina, Jiri Sana, Jan Zavadil, Jaroslav Juracek, Natalia Anna Gablo, Barbora Čechová, Ondrej Slaby, Marek Svoboda, Tana Machackova, Nahum Goldberg, Marek Vecera
Publikováno v:
Cancer Research. 78:521-521
Introduction: The majority of primary or metastatic liver tumors are unresectable (because of tumor size, location, poor performance status or multifocality), therefore other therapeutic modalities as radiofrequency ablation (RFA) and transarterial c
Autor:
Natalia Anna Gablo, Marek Vecera, Tana Machackova, Alena Kopková, Parwez Ahmad, Jiri Sana, Ondrej Slaby, Pavel Fadrus, Jaroslav Juracek, Marek Svoboda
Publikováno v:
Cancer Research. 78:3615-3615
Introduction: Cerebrospinal fluid (CSF) is a body fluid with many important functions that is in direct contact with the extracellular environment of the central nervous system (CSN). Therefore, CSF serves inter alia as a both communication channel a